Fibrillar β-Amyloid Induces Microglial Phagocytosis, Expression of Inducible Nitric Oxide Synthase, and Loss of a Select Population of Neurons in the Rat CNS In Vivo
Open accessAbstract
To determine the stability of β-amyloid peptide (Aβ) and the glial and neuronal changes induced by Aβ in the CNS in vivo, we made single injections of fibrillar Aβ (fAβ), soluble Aβ (sAβ), or vehicle into the rat striatum. Injected fAβ is stable in vivo for at least 30 d after injection, whereas sAβ is primarily cleared within 1 d. After injection of fAβ, microglia phagocytize fAβ aggregates, whereas nearby astrocytes form a virtual wall between fAβ-containing microglia and the surrounding neuropil. Similar glial changes are not observed after sAβ injection. Microglia and astrocytes near the injected fAβ show a significant increase in inducible nitric oxide synthase (iNOS) expression compared with that seen with sAβ or vehicle injection. Injection of fAβ but not sAβ or vehicle induces a significant loss of parvalbumin- and neuronal nitric oxide synthase-immunoreactive neurons, whereas the number of calbindin-immunoreactive neurons remains unchanged. These data demonstrate that fAβ is remarkably stable in the CNS in vivo and suggest that fAβ neurotoxicity is mediated in large part by factors released from activated microglia and astrocytes, as opposed to direct interaction between Aβ fibrils and neurons.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Neuroinflammation is a key contributor to Alzheimer's disease progression; prolonged activation of microglia and astrocytes leads to chronic inflammation and release of pro-inflammatory cytokines such as IL-1β and TNF-α, promoting neuronal damage in vulnerable brain regions like the neocortex and hippocampus.
“Neuroinflammation is a key contributor to AD progression. While early immune responses may aid in the clearance of Aβ and tau aggregates, prolonged activation of microglia and astrocytes leads to chronic inflammation and the release of pro-inflammatory cytokines such as IL-1β and TNF-α, promoting neuronal damage in vulnerable brain regions like the neocortex and hippocampus [34–36].”
From Targeted Nanoparticles for Drug Delivery Across the Blood–Brain Barrier in Early and Late Stages of Alzheimer's Disease: A Review (2026) · cites this paper as [36]
The citation lists haven’t been fetched yet
References 90 · Cited by 348
- Authors
- Weldon, D. T., Rogers, S. D., Ghilardi, J. R., Finke, M. P., Cleary, J. P., O’Hare, E., Esler, W. P., Maggio, J. E., & Mantyh, P. W.
- Affiliations
- Minneapolis VA Medical Center (US)
- University of Cincinnati (US)
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 1998-03-15
- Volume
- 18
- Issue
- 6
- Pages
- 2161-2173
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC6792921
- OpenAlex
- W1729010372
- Cited by
- 348
- References
- 90
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 4 · 2023: 6 · 2022: 6 · 2021: 8 · 2020: 13 · 2019: 6 · 2018: 9 · 2017: 7 · 2016: 8 · 2015: 6 · 2014: 12 · 2013: 11 · 2012: 17
- FWCI
- 12.29
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Alzheimer's Association
- National Institutes of Health (5r01ag011852-02, NS23970)
- National Institute on Aging (AG11852, R01AG012853, AG12853)
- National Institute of Neurological Disorders and Stroke (NS23970)
- Topics
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- microglial phagocytosis, inducible nitric oxide synthase, astrocytes, neuronal loss, parvalbumin neurons, neuronal nitric oxide synthase, striatum, neurotoxicity, Alzheimer's disease
- MeSH terms
- Animals, Astrocytes, Brain, Cell Count, Drug Stability, Enzyme Induction, Injections, Male, Neurons, Phagocytosis, Solubility, Amyloid beta-Peptides, Rats, Sprague-Dawley, Microglia, Nitric Oxide Synthase, Rats, Nitric Oxide Synthase Type II
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review